Is dendreon a good buy at 12.50???

Quote












Not for long term growth if that is your goal. Company could be bought but if the uptake is poor now I would not expect it to grow substantially. There are better buys out there than the topsy turvey life cycle of DNDN. I thought about buying and catching it on the rebound which I have before, but I am at a point that Wall Street has finally spoken the last word on this stock and that word is 'run'.

I feel bad for the folks that went there and left good jobs for a chance to make some coin. If I was there, I would seriously be looking.

Peace!
 






DNDN will get bought, but for no more than 20 a share. So if you are high enough up the food chain to get a bunch of restricted shares, you will do OK. If you are banking on your options, tough luck.
 






Px should get back to $ 15 by year end if west coast plant gets approved Aug 28 and they show any kind of reasonable growth. $50 could be years, if ever, even in buyout.
 






The therapy is a good one, and the guidance was terrible. that's it in a nutshell.

Had the guidance been 250 mm would this be such a bad situation? It's the first full year of the product and we just now got stable news from CMS for reimbursement, so where is all the hatred coming from?

Nobody thinks the executive team is great, but the sales are growing steadily and will continue now that reimbursement has stabilized in the minds of the providers.

How can the stock remain depressed when sales increase by 15-25% each quarter? I may be naive about how how stock prices work, but won't steady growth after 3-4 quarters right the ship in the public's eye? I think $12 is a steal. 12-month growth should put stock at 25 at least, despite dipsticks running the show.
 






Anonymous said:
The therapy is a good one, and the guidance was terrible. that's it in a nutshell.

Had the guidance been 250 mm would this be such a bad situation? It's the first full year of the product and we just now got stable news from CMS for reimbursement, so where is all the hatred coming from?

Nobody thinks the executive team is great, but the sales are growing steadily and will continue now that reimbursement has stabilized in the minds of the providers.

How can the stock remain depressed when sales increase by 15-25% each quarter? I may be naive about how how stock prices work, but won't steady growth after 3-4 quarters right the ship in the public's eye? I think $12 is a steal. 12-month growth should put stock at 25 at least, despite dipsticks running the show.
Click to expand...


Bull manure!
 






Anonymous said:
The therapy is a good one, and the guidance was terrible. that's it in a nutshell.

Had the guidance been 250 mm would this be such a bad situation? It's the first full year of the product and we just now got stable news from CMS for reimbursement, so where is all the hatred coming from?

Nobody thinks the executive team is great, but the sales are growing steadily and will continue now that reimbursement has stabilized in the minds of the providers.

How can the stock remain depressed when sales increase by 15-25% each quarter? I may be naive about how how stock prices work, but won't steady growth after 3-4 quarters right the ship in the public's eye? I think $12 is a steal. 12-month growth should put stock at 25 at least, despite dipsticks running the show.
Click to expand...



Thanks Hans!!!!!
 






Anonymous said:
The therapy is a good one, and the guidance was terrible. that's it in a nutshell.

Had the guidance been 250 mm would this be such a bad situation? It's the first full year of the product and we just now got stable news from CMS for reimbursement, so where is all the hatred coming from?

Nobody thinks the executive team is great, but the sales are growing steadily and will continue now that reimbursement has stabilized in the minds of the providers.

How can the stock remain depressed when sales increase by 15-25% each quarter? I may be naive about how how stock prices work, but won't steady growth after 3-4 quarters right the ship in the public's eye? I think $12 is a steal. 12-month growth should put stock at 25 at least, despite dipsticks running the show.
Click to expand...

Stock should hit 15 within 6-12 months.
 






Top Bottom
Back
Quote